Skip to main content

Table 1 Baseline characteristics of the study groups

From: Effect of minocycline on the left ventricular function following ST-elevation myocardial infarction treated by primary percutaneous coronary intervention

Characteristic

Control (n=39)

Intervention (n=34)

P value*

Age, year

57.3±9.1

56.5±10.7

0.749

Male gender, n (%)

32 (82.1)

31 (91.2)

0.321

BMI, kg/m2

27.5±4.3

28.1±2.9

0.510

Diabetes mellitus, n (%)

4 (10.3)

6 (17.6)

0.499

Hypertension, n (%)

18 (46.2)

10 (29.4)

0.142

Dyslipidemia, n (%)

14 (35.9)

20 (58.8)

0.050

Smoking, n (%)

15 (38.5)

12 (35.3)

0.780

Family history of CAD, n (%)

5 (12.8)

4 (11.8)

0.999

Cholesterol, mg/dl

176.6±47.0

173.4±37.2

0.750

Triglyceride, mg/dl

125.0 [88.0, 155.0]

120.0 [78.5, 161.0]

0.932

LDL, mg/dl

114.0 [84.0, 133.0]

112.0 [88.0, 132.5]

0.906

HDL, mg/dl

40.0±8.9

39.6±9.5

0.857

Fasting blood sugar, mg/dl

110.0 [98.0, 126.0]

119.5 [99.0, 137.0]

0.210

Creatinine, mg/dl

0.88±0.17

0.90±0.19

0.645

MMP-9, μg/dl

111.0±20.0

106.5±27.4

0.437

  1. BMI body mass index, bpm beats per minute, CAD coronary artery disease, HDL high-density lipoprotein, LDL low-density lipoprotein, MMP matrix metalloproteinase
  2. *P value less than 0.05 was considered as statistically significant